Elite Pharmaceuticals Inc /Nv/ Q1 FY2026 Earnings Call

Elite Pharmaceuticals Inc /Nv/ (ELTP)

Earnings Call FY2026 Q1 Call date: 2025-08-14 Concluded

Quarter scorecard

Revenue

$40.21M

+113.9% YoY

Diluted EPS

$-0.01

Gross margin

67.7%

+22.6 pp YoY

Net income

-1055.7% YoY

Manufacturing $39.78M

+115.7%

Licensing $433,334

+20.7%